Three dysregulated miRNAs control kallikrein 10 expression and cell proliferation in ovarian cancer

British Journal of Cancer

Volumn 102, Issue 8, 2010, Pages 1244-1253

  White, N M A ^a,b   Chow, T F F ^a   Mejia Guerrero, S ^a,b   Diamandis, M ^b   Rofael, Y ^a   Faragalla, H ^a,b   Mankaruous, M ^a   Gabril, M ^c   Girgis, A ^a   Yousef, G M ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Bioinformatics; Kallikrein; KLK; MiRNA; Ovarian cancer; Tumour markers

Indexed keywords

KALLIKREIN; LUCIFERASE; MICRORNA;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; COMPUTER MODEL; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOTHESIS; OVARY CANCER; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNTRANSLATED REGION;

BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KALLIKREINS; MICRORNAS; MOLECULAR SEQUENCE DATA; OVARIAN NEOPLASMS; PHYLOGENY; TRANSFECTION;

EID: 77950860321     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605634     Document Type: Article

References (85)

1. Ambros V, Bartel B, Bartel DP, Burge CB, Carrington JC, Chen X, Dreyfuss G, Eddy SR, Griffiths-Jones S, Marshall M, Matzke M, Ruvkun G, Tuschl T (2003) A uniform system for microRNA annotation. RNA 9: 277-279 (Pubitemid 36246165)
2. Arora A, Guduric-Fuchs J, Harwood L, Dellett M, Cogliati T, Simpson DA (2010) Prediction of microRNAs affecting mRNA expression during retinal development. BMC Dev Biol 10: 1
3. Bando Y, Ito S, Nagai Y, Terayama R, Kishibe M, Jiang YP, Mitrovic B, Takahashi T, Yoshida S (2006) Implications of protease M/neurosin in myelination during experimental demyelination and remyelination. Neurosci Lett 405: 175-180 (Pubitemid 44189711)
4. Baudis M, Cleary ML (2001) Progenetix.net: an online repository for molecular cytogenetic aberration data. Bioinformatics 17: 1228-1229 (Pubitemid 33735351)
5. Bayani J, Paliouras M, Planque C, Shan SJ, Graham C, Squire JA, Diamandis EP (2008) Impact of cytogenetic and genomic aberrations of the kallikrein locus in ovarian cancer. Mol Oncol 2: 250-260
6. Bearfoot JL, Choong DY, Gorringe KL, Campbell IG (2008) Genetic analysis of cancer-implicated microRNA in ovarian cancer. Clin Cancer Res 14: 7246-7250
7. Boren T, Xiong Y, Hakam A, Wenham R, Apte S, Chan G, Kamath SG, Chen DT, Dressman H, Lancaster JM (2009) MicroRNAs and their target messenger RNAs associated with ovarian cancer response to chemotherapy. Gynecol Oncol 113: 249-255
8. Borgono CA, Fracchioli S, Yousef GM, Rigault De La Longrais IA, Luo LY, Soosaipillai A, Puopolo M, Grass L, Scorilas A, Diamandis EP, Katsaros D (2003) Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma. Int J Cancer 106: 605-610 (Pubitemid 36966221)
9. Borgono CA, Kishi T, Scorilas A, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP (2006) Human kallikrein 8 protein is a favorable prognostic marker in ovarian cancer. Clin Cancer Res 12: 1487-1493
10. Brucks JA (1992) Ovarian cancer. The most lethal gynecologic malignancy. Nurs Clin North Am 27: 835-845
11. Calin GA, Croce CM (2006a) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866
12. Calin GA, Croce CM (2006b) MicroRNAs and chromosomal abnormalities in cancer cells. Oncogene 25: 6202-6210 (Pubitemid 44527851)
13. Chow TF, crow M, Earle T, El-Said H, Diamandis EP, Yousef GM (2008) Kallikreins as microRNA targets: an in silico and experimental-based analysis. Biol Chem 389: 731-738 (Pubitemid 352009404)
14. Clements JA, Willemsen NM, Myers SA, Dong Y (2004) The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers. Crit Rev Clin Lab Sci 41: 265-312 (Pubitemid 38888061)
15. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih I, Zhang Y, Wood III W, Becker KG, Morin PJ (2008) MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 3: e2436
16. Diamandis EP, Scorilas A, Fracchioli S, Van Gramberen M, De Bruijn H, Henrik A, Soosaipillai A, Grass L, Yousef GM, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Katsaros D (2003) Human kallikrein 6 (hK6): a new potential serum biomarker for diagnosis and prognosis of ovarian carcinoma. J Clin Oncol 21: 1035-1043 (Pubitemid 46594132)
17. Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA (2003) Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. Clin Cancer Res 9: 1710-1720 (Pubitemid 36554595)
18. Dong Y, Kaushal A, Bui L, Chu S, Fuller PJ, Nicklin J, Samaratunga H, Clements JA (2001) Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. Clin Cancer Res 7: 2363-2371 (Pubitemid 32751637)
19. Dorn J, Schmitt M, Kates R, Schmalfeldt B, Kiechle M, Scorilas A, Diamandis EP, Harbeck N (2007) Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients. Clin Cancer Res 13: 1742-1748 (Pubitemid 46952940)
20. Emami N, Diamandis EP (2007) Human tissue kallikreins: a road under construction. Clin Chim Acta 381: 78-84 (Pubitemid 46719134)
21. Emami N, Diamandis EP (2008) Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers. Clin Chem 54: 1600-1607
22. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269
23. Garzon R, Fabbri M, Cimmino A, Calin GA, Croce CM (2006) MicroRNA expression and function in cancer. Trends Mol Med 12: 580-587 (Pubitemid 44780201)
24. Hoffman BR, Katsaros D, Scorilas A, Diamandis P, Fracchioli S, Rigault de la Longrais IA, Colgan T, Puopolo M, Giardina G, Massobrio M, Diamandis EP (2002) Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker. Br J Cancer 87: 763-771 (Pubitemid 35178754)
25. Iorio MV, Visone R, Di LG, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H, Calin GA, Menard S, Croce CM (2007) MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699-8707 (Pubitemid 47437445)
26. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS (2004) Human microRNA targets. PLoS Biol 2: e363 (Pubitemid 40280484)
27. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D (2002) The human genome browser at UCSC. Genome Res 12: 996-1006 (Pubitemid 34662293)
28. Kim H, Scorilas A, Katsaros D, Yousef GM, Massobrio M, Fracchioli S, Piccinno R, Gordini G, Diamandis EP (2001) Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer. Br J Cancer 84: 643-650 (Pubitemid 32238998)
29. Klokk TI, Kilander A, Xi Z, Waehre H, Risberg B, Danielsen HE, Saatcioglu F (2007) Kallikrein 4 is a proliferative factor that is overexpressed in prostate cancer. Cancer Res 67: 5221-5230 (Pubitemid 46997260)
30. Kountourakis P, Psyrri A, Scorilas A, Camp R, Markakis S, Kowalski D, Diamandis EP, Dimopoulos MA (2008) Prognostic value of kallikreinrelated peptidase 6 protein expression levels in advanced ovarian cancer evaluated by automated quantitative analysis (AQUA). Cancer Sci 99: 2224-2229
31. Kountourakis P, Psyrri A, Scorilas A, Markakis S, Kowalski D, Camp RL, Diamandis EP, Dimopoulos MA (2009) Expression and prognostic significance of kallikrein-related peptidase 8 protein levels in advanced ovarian cancer by using automated quantitative analysis. Thromb Haemost 101: 541-546
32. Kurlender L, Borgono C, Michael IP, Obiezu C, Elliott MB, Yousef GM, Diamandis EP (2005) A survey of alternative transcripts of human tissue kallikrein genes. Biochim Biophys Acta 1755: 1-14 (Pubitemid 40720237)
33. Kyriakopoulou LG, Yousef GM, Scorilas A, Katsaros D, Massobrio M, Fracchioli S, Diamandis EP (2003) Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer. Clin Biochem 36: 135-143 (Pubitemid 36287493)
34. Lai J, Myers SA, Lawrence MG, Odorico DM, Clements JA (2009) Direct progesterone receptor and indirect androgen receptor interactions with the kallikrein-related peptidase 4 gene promoter in breast and prostate cancer. Mol Cancer Res 7: 129-141
35. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20
36. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB (2003) Prediction of mammalian microRNA targets. Cell 115: 787-798
37. Lim LP, Lau NC, Garrett-Engele P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM (2005) Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433: 769-773 (Pubitemid 40292988)
38. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Bellino R, Van Gramberen M, De Bruijn H, Henrik A, Stenman UH, Massobrio M, Van Der Zee AG, Vergote I, Diamandis EP (2003) The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis. Cancer Res 63: 807-811 (Pubitemid 36231980)
39. Luo LY, Katsaros D, Scorilas A, Fracchioli S, Piccinno R, Rigault De La Longrais IA, Howarth DJ, Diamandis EP (2001) Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma. Clin Cancer Res 7: 2372-2379 (Pubitemid 32751638)
40. Luo LY, Soosaipillai A, Grass L, Diamandis EP (2006) Characterization of human kallikreins 6 and 10 in ascites fluid from ovarian cancer patients. Tumour Biol 27: 227-234 (Pubitemid 44260247)
41. Mange A, Desmetz C, Berthes ML, Maudelonde T, Solassol J (2008) Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells. Biochem Biophys Res Commun 375: 107-112
42. Mees ST, Mardin WA, Sielker S, Willscher E, Senninger N, Schleicher C, Colombo-Benkmann M, Haier J (2009) Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas. Ann Surg Oncol 16(8): 2339-2350
43. Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I (2006) A pattern-based method for the identification of microRNA binding sites and their corresponding heteroduplexes. Cell 126: 1203-1217 (Pubitemid 44380294)
44. Nakamoto M, Jin P, O'Donnell WT, Warren ST (2005) Physiological identification of human transcripts translationally regulated by a specific microRNA. Hum Mol Genet 14: 3813-3821 (Pubitemid 43020083)
45. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH, Kim JW, Kim S (2008) MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695
46. Ni X, Zhang W, Huang KC, Wang Y, Ng SK, Mok SC, Berkowitz RS, Ng SW (2004) Characterisation of human kallikrein 6/protease M expression in ovarian cancer. Br J Cancer 91: 725-731 (Pubitemid 39141632)
47. Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93: 1600-1608 (Pubitemid 351656494)
48. Nishi H, Ono K, Iwanaga Y, Horie T, Nagao K, Takemura G, Kinoshita M, Kuwabara Y, Takanabe-Mori R, Hasegawa K, Kita T, Kimura T (2009) MICRORNA-15B modulates cellular ATP levels and degenerates mitochondria via ARL2 in neonatal rat cardiac myocytes. J Biol Chem 285(7): 4920-4930
49. Pampalakis G, Sotiropoulou G (2006) Multiple mechanisms underlie the aberrant expression of the human kallikrein 6 gene in breast cancer. Biol Chem 387: 773-782 (Pubitemid 43964800)
50. Pan YZ, Morris ME, Yu AM (2009) MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 75: 1374-1379
51. Pettus JR, Johnson JJ, Shi Z, Davis JW, Koblinski J, Ghosh S, Liu Y, Ravosa MJ, Frazier S, Stack MS (2009) Multiple kallikrein (KLK 5, 7, 8, and 10) expression in squamous cell carcinoma of the oral cavity. Histol Histopathol 24: 197-207
52. Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, Schmitt M, Talieri M, Diamandis EP, Kruger A, Magdolen V (2006) Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem 387: 807-811 (Pubitemid 43964805)
53. Prueitt RL, Yi M, Hudson RS, Wallace TA, Howe TM, Yfantis HG, Lee DH, Stephens RM, Liu CG, Calin GA, Croce CM, Ambs S (2008) Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 68: 1152-1164
54. Qu Y, Zhao S, Hong J, Tang S (2009) Radiosensitive gene therapy through imRNA expression for silencing manganese superoxide dismutase. J Cancer Res Clin Oncol, doi:10.1007/s00432-009-0739-5 [doi]
55. Rajewsky N, Socci ND (2004) Computational identification of microRNA targets. Dev Biol 267: 529-535 (Pubitemid 38328590)
56. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE (2009) The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 112: 55-59
57. Scorilas A, Borgono CA, Harbeck N, Dorn J, Schmalfeldt B, Schmitt M, Diamandis EP (2004) Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker. J Clin Oncol 22: 678-685 (Pubitemid 41095071)
58. Sethupathy P, Megraw M, Hatzigeorgiou AG (2006) A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods 3: 881-886 (Pubitemid 44614721)
59. Shan SJ, Scorilas A, Katsaros D, Diamandis EP (2007) Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects. Br J Cancer 96: 362-372 (Pubitemid 46160644)
60. Shaw JL, Diamandis EP (2007) Distribution of 15 human kallikreins in tissues and biological fluids. Clin Chem 53: 1423-1432 (Pubitemid 47206338)
61. Shaw JL, Diamandis EP (2008) Regulation of human tissue kallikreinrelated peptidase expression by steroid hormones in 32 cell lines. Biol Chem 389: 1409-1419
62. Shigemasa K, Gu L, Tanimoto H, O'Brien TJ, Ohama K (2004) Human kallikrein gene 11 (KLK11) mRNA overexpression is associated with poor prognosis in patients with epithelial ovarian cancer. Clin Cancer Res 10: 2766-2770 (Pubitemid 38509153)
63. Shinoda Y, Kozaki K, Imoto I, Obara W, Tsuda H, Mizutani Y, Shuin T, Fujioka T, Miki T, Inazawa J (2007) Association of KLK5 overexpression with invasiveness of urinary bladder carcinoma cells. Cancer Sci 98: 1078-1086 (Pubitemid 46865394)
64. Shvartsman HS, Lu KH, Lee J, Lillie J, Deavers MT, Clifford S, Wolf JK, Mills GB, Bast Jr RC, Gershenson DM, Schmandt R (2003) Overexpression of kallikrein 10 in epithelial ovarian carcinomas. Gynecol Oncol 90: 44-50 (Pubitemid 37338074)
65. Stark A, Lin MF, Kheradpour P, Pedersen JS, Parts L, Carlson JW, Crosby MA, Rasmussen MD, Roy S, Deoras AN, Ruby JG, Brennecke J, Hodges E, Hinrichs AS, Caspi A, Paten B, Park SW, Han MV, Maeder ML, Polansky BJ, Robson BE, Aerts S, van HJ, Hassan B, Gilbert DG, Eastman DA, Rice M, Weir M, Hahn MW, Park Y, Dewey CN, Pachter L, Kent WJ, Haussler D, Lai EC, Bartel DP, Hannon GJ, Kaufman TC, Eisen MB, Clark AG, Smith D, Celniker SE, Gelbart WM, Kellis M (2007) Discovery of functional elements in 12 Drosophila genomes using evolutionary signatures. Nature 450: 219-232 (Pubitemid 350100553)
66. Tanimoto H, Underwood LJ, Shigemasa K, Parmley TH, O'Brien TJ (2001) Increased expression of protease M in ovarian tumors. Tumour Biol 22: 11-18
67. Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I (2008) MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation. Nature 455: 1124-1128
68. Taylor DD, Gercel-Taylor C (2008) MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol 110: 13-21 (Pubitemid 351853251)
69. Tong AW, Nemunaitis J (2008) Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? Cancer Gene Ther 15: 341-355 (Pubitemid 351693228)
70. Wang Y, Lee AT, Ma JZ, Wang J, Ren J, Yang Y, Tantoso E, Li KB, Ooi LL, Tan P, Lee CG (2008) Profiling microRNA expression in hepatocellular carcinoma reveals microRNA-224 up-regulation and apoptosis inhibitor-5 as a microRNA-224-specific target. J Biol Chem 283: 13205-13215
71. White NM, Mathews M, Yousef GM, Prizada A, Popadiuk C, Dore JJ (2009) KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma. Br J Cancer 101: 1107-1113
72. Xi Z, Klokk TI, Korkmaz K, Kurys P, Elbi C, Risberg B, Danielsen H, Loda M, Saatcioglu F (2004) Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer. Cancer Res 64: 2365-2370 (Pubitemid 38523888)
73. Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX, Shao JY (2008) MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA 14: 2348-2360
74. Yousef GM (2008) microRNAs: a new frontier in kallikrein research. Biol Chem 389: 689-694 (Pubitemid 352009401)
75. Yousef GM, Chang A, Scorilas A, Diamandis EP (2000) Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. Biochem Biophys Res Commun 276: 125-133
76. Yousef GM, Diamandis EP (1999) The new kallikrein-like gene, KLK-L2. Molecular characterization, mapping, tissue expression, and hormonal regulation. J Biol Chem 274: 37511-37516
77. Yousef GM, Diamandis EP (2002) Kallikreins, steroid hormones and ovarian cancer: is there a link? Minerva Endocrinol 27: 157-166
78. Yousef GM, Fracchioli S, Scorilas A, Borgono CA, Iskander L, Puopolo M, Massobrio M, Diamandis EP, Katsaros D (2003a) Steroid hormone regulation and prognostic value of the human kallikrein gene 14 in ovarian cancer. Am J Clin Pathol 119: 346-355 (Pubitemid 37047856)
79. Yousef GM, Kyriakopoulou LG, Scorilas A, Fracchioli S, Ghiringhello B, Zarghooni M, Chang A, Diamandis M, Giardina G, Hartwick WJ, Richiardi G, Massobrio M, Diamandis EP, Katsaros D (2001) Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker. Cancer Res 61: 7811-7818 (Pubitemid 33049369)
80. Yousef GM, Obiezu CV, Luo LY, Magklara A, Borgono CA, Kishi T, Memari N, Michael P, Sidiropoulos M, Kurlender L, Economopolou K, Kapadia C, Komatsu N, Petraki C, Elliott M, Scorilas A, Katsaros D, Levesque MA, Diamandis EP (2005) Human tissue kallikreins: from gene structure to function and clinical applications. Adv Clin Chem 39: 11-79
81. Yousef GM, Polymeris ME, Yacoub GM, Scorilas A, Soosaipillai A, Popalis C, Fracchioli S, Katsaros D, Diamandis EP (2003b) Parallel overexpression of seven kallikrein genes in ovarian cancer. Cancer Res 63: 2223-2227
82. Yousef GM, Scorilas A, Katsaros D, Fracchioli S, Iskander L, Borgono C, Rigault De La Longrais IA, Puopolo M, Massobrio M, Diamandis EP (2003c) Prognostic value of the human kallikrein gene 15 expression in ovarian cancer. J Clin Oncol 21: 3119-3126 (Pubitemid 46606293)
83. Yousef GM, Scorilas A, Kyriakopoulou LG, Rendl L, Diamandis M, Ponzone R, Biglia N, Giai M, Roagna R, Sismondi P, Diamandis EP (2002) Human kallikrein gene 5 (KLK5) expression by quantitative PCR: an independent indicator of poor prognosis in breast cancer. Clin Chem 48: 1241-1250 (Pubitemid 34809832)
84. Yu Z, Raabe T, Hecht NB (2005) MicroRNA Mirn122a reduces expression of the posttranscriptionally regulated germ cell transition protein 2 (Tnp2) messenger RNA (mRNA) by mRNA cleavage. Biol Reprod 73: 427-433
85. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Butzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 105: 7004-7009